Facebook Linkedin RSS Twitter Youtube
Home 2024

Drug design

Risk of Diabetes Caused by Antipsychotics Decreased by Pancreas Specific Dopamine Agonist
Drug Discovery

Risk of Diabetes Caused by Antipsychotics Decreased by Pancreas Specific Dopamine Agonist

Extended Reality Helps Drug Designers Realize Bold Visions
Artificial Intelligence

Extended Reality Helps Drug Designers Realize Bold Visions

BMS Invests $400M in Ireland Campus for New Sterile Drug Product Facility
Bioprocessing

BMS Invests $400M in Ireland Campus for New Sterile Drug Product Facility

TFF to Purify Crystalized mAbs and Other Proteins
Bioprocessing

TFF to Purify Crystalized mAbs and Other Proteins

Synthetic Dreams: Data and AI Catalyze Drug Innovation
Artificial Intelligence

Synthetic Dreams: Data and AI Catalyze Drug Innovation

Neurotransmitter Transporter’s Structures Suggest New Drug Strategies
Drug Discovery

Neurotransmitter Transporter’s Structures Suggest New Drug Strategies

How Oligonucleotide Therapeutics May Change the Course of Rare Diseases
Drug Discovery

How Oligonucleotide Therapeutics May Change the Course of Rare Diseases

Enhanced Efficacy for Next-Gen Antibody Therapies
Bioprocessing

Enhanced Efficacy for Next-Gen Antibody Therapies

Ordaōs Uses AI to Generate Therapeutic Mini-Proteins
Artificial Intelligence

Ordaōs Uses AI to Generate Therapeutic Mini-Proteins

Insilico’s AI Tackles Lysosomal Storage Disorder, IPF Drug Gets Inhalable Formula
Artificial Intelligence

Insilico’s AI Tackles Lysosomal Storage Disorder, IPF Drug Gets Inhalable Formula

123...10Page 1 of 10
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.